Kidney disease is highly prevalent and results in premature mortality, comorbid illnesses, reduced quality of life, and substantial healthcare costs. Given the vast scope of the kidney disease epidemic, there is a critical need to train scientists who can conduct high-impact research that addresses this massive health problem. This proposal is a competitive renewal application, years 26 to 30, for a NRSA to fund our Kidney Disease Epidemiology and Clinical Research Training Program at Hopkins. The goal of this program is to identify and train scientists who have the potential to become leaders in the design and conduct of epidemiologic, clinical and translational research related to kidney disease. The Program is based in the Welch Center for Prevention, Epidemiology, and Clinical Research. It takes advantage of the faculty?s strengths in the application of rigorous methodology to study kidney disease; their ability to design interdisciplinary, high-impact research; and their dedication to education and mentorship. The program Director (Dr. Appel), Associate Directors (Drs. Fadrowski, Grams, Segev), and 14 other nationally recognized kidney disease researchers serve as core faculty, and another 11 faculty serve as affiliate faculty. An Advisory Committee of institutional leaders and accomplished researchers advise the program?s leadership and monitor its progress. Our training program has been highly successful. We have recruited exceptionally high-quality candidates, provided them with rigorous training, and helped launch their research careers. Over the last 15 years, we supported 31 post-doctoral trainees (77% women, 10% underrepresented minorities). Of the 25 graduates, 24 are pursuing academic careers, and the vast majority are scientists; 12 received federal grants (11 K awardees). The NRSA funding has established Hopkins as a pre-eminent academic center for the design and conduct of clinical, epidemiologic and translational research related to kidney disease; spawned new research programs (e.g. the CKD Prognosis Consortium and the Kidney Transplant Outcomes program) and new education initiatives (e.g. kidney disease epidemiology course); revitalized the Pediatric Nephrology fellowship; forged close collaborative relations across schools and academic units; and most importantly, produced a cadre of extremely successful young investigators who are doing innovative research at institutions across the U.S. Still, we will not rest on our laurels. With funding from this application, we intend to increase the size of our training program from 4 to 6 post-doctoral trainees, expand the core faculty (including luminaries recruited from other institutions: D. Brennan, C. Chute, and C. Parikh), and enhance trainee recruitment efforts, especially targeted at enrolling under-represented minorities. Ultimately, this T32 will meet a critical goal of NIDDK, i.e. broadening the pool of well-trained researchers conducting impactful kidney disease research.

Public Health Relevance

The need for well-trained scientists to conduct impactful research on epidemiologic, clinical and translational aspects of kidney disease is substantial. The T32 Kidney Disease Epidemiology Training Program at Johns Hopkins has a stellar reputation for identifying and training researchers who can meet this need.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Institutional National Research Service Award (T32)
Project #
2T32DK007732-26
Application #
9934544
Study Section
Kidney, Urologic and Hematologic Diseases D Subcommittee (DDK)
Program Officer
Spruance, Victoria Marie
Project Start
1995-09-20
Project End
2025-06-30
Budget Start
2020-07-01
Budget End
2021-06-30
Support Year
26
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Public Health & Prev Medicine
Type
Schools of Public Health
DUNS #
001910777
City
Baltimore
State
MD
Country
United States
Zip Code
21205
Van Pilsum Rasmussen, Sarah; Konel, Jonathan; Warsame, Fatima et al. (2018) Engaging clinicians and patients to assess and improve frailty measurement in adults with end stage renal disease. BMC Nephrol 19:8
Juraschek, Stephen P; Miller 3rd, Edgar R; Appel, Lawrence J (2018) Orthostatic Hypotension and Symptoms in the AASK Trial. Am J Hypertens 31:665-671
Juraschek, Stephen P; Plante, Timothy B; Charleston, Jeanne et al. (2018) Use of online recruitment strategies in a randomized trial of cancer survivors. Clin Trials 15:130-138
Shaffer, Ashton A; Thomas, Alvin G; Bowring, Mary Grace et al. (2018) Changes in practice and perception of hepatitis C and liver transplantation: Results of a national survey. Transpl Infect Dis 20:e12982
Warsame, Fatima; Haugen, Christine E; Ying, Hao et al. (2018) Limited health literacy and adverse outcomes among kidney transplant candidates. Am J Transplant :
Pilla, Scott J; Yeh, Hsin-Chieh; Juraschek, Stephen P et al. (2018) Predictors of Insulin Initiation in Patients with Type 2 Diabetes: An Analysis of the Look AHEAD Randomized Trial. J Gen Intern Med 33:839-846
Michos, Erin D; Mitchell, Christine M; Miller 3rd, Edgar R et al. (2018) Rationale and design of the Study To Understand Fall Reduction and Vitamin D in You (STURDY): A randomized clinical trial of Vitamin D supplement doses for the prevention of falls in older adults. Contemp Clin Trials 73:111-122
Juraschek, Stephen P; Woodward, Mark; Sacks, Frank M et al. (2017) Time Course of Change in Blood Pressure From Sodium Reduction and the DASH Diet. Hypertension 70:923-929
McAdams-DeMarco, Mara A; King, Elizabeth A; Luo, Xun et al. (2017) Frailty, Length of Stay, and Mortality in Kidney Transplant Recipients: A National Registry and Prospective Cohort Study. Ann Surg 266:1084-1090
Toth-Manikowski, Stephanie M; Mullangi, Surekha; Hwang, Seungyoung et al. (2017) Incremental short daily home hemodialysis: a case series. BMC Nephrol 18:216

Showing the most recent 10 out of 95 publications